These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19997655)

  • 1. Elevated advanced oxidation protein products levels in patients with liver cirrhosis.
    Zuwała-Jagiełło J; Pazgan-Simon M; Simon K; Warwas M
    Acta Biochim Pol; 2009; 56(4):679-85. PubMed ID: 19997655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis.
    Zuwała-Jagiełło J; Pazgan-Simon M; Simon K; Warwas M
    Acta Biochim Pol; 2011; 58(1):59-65. PubMed ID: 21403920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
    Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
    J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.
    Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene.
    Spatari G; Saitta S; Cimino F; Sapienza D; Quattrocchi P; Carrieri M; Barbaro M; Saija A; Gangemi S
    Int J Hyg Environ Health; 2012 Apr; 215(3):389-92. PubMed ID: 22153878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia.
    Gangemi S; Allegra A; Aguennouz M; Alonci A; Speciale A; Cannavò A; Cristani M; Russo S; Spatari G; Alibrandi A; Musolino C
    Cancer Invest; 2012 Jan; 30(1):20-6. PubMed ID: 22236186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of advanced glycation end-products with glutathione status.
    Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum selenium levels in cirrhotic patients are not influenced by the disease severity index.
    Martínez-Peinado M; Nogueras-López F; Arcos-Cebrián A; Agil A; Navarro-Alarcón M
    Nutr Res; 2010 Aug; 30(8):574-8. PubMed ID: 20851312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
    Sebeková K; Gazdíková K; Syrová D; Blazícek P; Schinzel R; Heidland A; Spustová V; Dzúrik R
    J Hum Hypertens; 2003 Apr; 17(4):265-70. PubMed ID: 12692571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased protein glycation in cirrhosis and therapeutic strategies to prevent it.
    Ahmed N; Lüthen R; Häussinger D; Sebeková K; Schinzel R; Voelker W; Heidland A; Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():718-24. PubMed ID: 16037298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy.
    Llurba E; Gratacós E; Martín-Gallán P; Cabero L; Dominguez C
    Free Radic Biol Med; 2004 Aug; 37(4):557-70. PubMed ID: 15256227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
    Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
    J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
    BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H; Wang H; Sun Y; Guo F; Fang JL; Shao J; Rao HY; Wang J; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.